Product category:
Clinical chemistry analysis
News Release from: Inverness Medical Innovations | Subject: Clearview Chlamydia MF test
Edited by the Laboratorytalk Editorial
Team on 24 January 2008
Chlamydia diagnosis and treatment in
single visit
Giving results in as little as 30 minutes, Clearview Chlamydia MF is suitable for men and women by detecting chlamydia trachomatis antigen using either female endocervical swabs or male urine samples
For the rapid testing and swift diagnosis of chlamydia trachomatis infection, Inverness Medical offers the Clearview Chlamydia MF test It is estimated that there are 92 million chlamydia infections a year, making it the most common sexually transmitted disease worldwide
This article was originally published on Laboratorytalk on 8 Jul 2008 at 8.00am (UK)
Related stories
Detect C difficile infection in under 30 minutes
Clostridium difficile is responsible for the most common form of hospital-acquired diarrhoea, affecting over 500,000 people in the USA and one out of every 1000 patients hospitalised in Europe
Although treatable, the challenge in diagnosing chlamydia is often the lack of symptoms.
With as many as a quarter of patients never returning for their results and treatment, Clearview Chlamydia MF ensures diagnosis and treatment can be made in a single patient visit, reducing patient anxiety and the spread of infection.
The easy-to-use lateral flow test has in-built procedural controls which reliably confirm the test has worked correctly.
The test uses a unique heating step in the testing process which gives Clearview Chlamydia MF its high sensitivity, meaning clinicians can be confident in the test results.
Early treatment of Chlamydia is essential in preventing the development of future complications.
In women, if left untreated Chlamydia can cause infertility and an increased risk of ectopic pregnancies.
In men the infection can cause arthritis, as well as damage to sperm.
With Clearview Chlamydia MF, Inverness Medical offers a practical answer to improving patient care and reducing the rise in this easily treatable infection.
• Inverness Medical Innovations: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
